Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Higher diabetes prevalence in ACS warrants routine screening; leaves open whether targeted interventions reduce mortality.
Diabetes mellitus is a common risk profile and quality-of-life damaging factor in patients with acute coronary syndrome (ACS) and an important leading cause of mortality and morbidity in these patients. According to the American Diabetes Association report, although the prevalence of diabetes mellitus among general population was estimated at less than 9%, this estimated prevalence in ACS patients is considerably higher (1-3).
No takes yet. Share an insight, caveat, or question.
Nejatian et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: